Hospital Mater Dei (BSP:MATD3) Accounts Payable & Accrued Expense: R$261 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:MATD3 Hospital Mater Dei SA BSP:MATD3
83 GF Score
Price R$4.94
GF Value R$5.67
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Hospital Mater Dei Accounts Payable & Accrued Expense?

Hospital Mater Dei BSP:MATD3 83 Accounts Payable & Accrued Expense is R$261 Mil as of Jun. 2026. GuruFocus rates BSP:MATD3 with a GF Score™ of 83/100 and a GF Value™ of R$5.67 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Hospital Mater Dei's quarterly accounts payable & accrued expense increased from Dec. 2025 (R$218 Mil) to Mar. 2026 (R$258 Mil) and increased from Mar. 2026 (R$258 Mil) to Jun. 2026 (R$261 Mil).

Hospital Mater Dei's annual accounts payable & accrued expense declined from Dec. 2023 (R$266 Mil) to Dec. 2024 (R$200 Mil) but then increased from Dec. 2024 (R$200 Mil) to Dec. 2025 (R$218 Mil).

Hospital Mater Dei Accounts Payable & Accrued Expense Historical Data

* Premium members only.

The historical data trend for Hospital Mater Dei's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hospital Mater Dei Accounts Payable & Accrued Expense Chart

Hospital Mater Dei Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only 172.83 235.31 265.79 199.86 218.18

Hospital Mater Dei Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 189.42 211.10 218.18 258.27 260.52
BSP:MATD3
83GF Score
Hospital Mater Dei SA BSP:MATD3
Accounts Payable & Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hospital Mater Dei Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

What does a Accounts Payable & Accrued Expense of R$261 Mil mean?
Hospital Mater Dei (BSP:MATD3) has a Accounts Payable & Accrued Expense of R$261 Mil as of Jun. 2026. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on Hospital Mater Dei and its competitors.
Is Hospital Mater Dei's Accounts Payable & Accrued Expense too high?
Hospital Mater Dei's current Accounts Payable & Accrued Expense is R$261 Mil. Overall, Hospital Mater Dei has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hospital Mater Dei's Accounts Payable & Accrued Expense compare to HCA and THC?
Hospital Mater Dei's Accounts Payable & Accrued Expense of R$261 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable & Accrued Expense for a Healthcare Providers & Services company?
A good Accounts Payable & Accrued Expense depends on the Healthcare Providers & Services industry context. However, Accounts Payable & Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable & Accrued Expense mean?
A high Accounts Payable & Accrued Expense can signal that a stock is expensive relative to its fundamentals. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on Hospital Mater Dei and its competitors. Hospital Mater Dei's current Accounts Payable & Accrued Expense is R$261 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hospital Mater Dei stock overvalued right now?
Based on GuruFocus' analysis, Hospital Mater Dei (BSP:MATD3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$5.67, compared to a current price of R$4.94 — trading 12.9% below its estimated fair value. The current Accounts Payable & Accrued Expense is R$261 Mil. Hospital Mater Dei's overall GF Score™ is 83/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable & Accrued Expense calculated?
Accounts Payable & Accrued Expense is calculated from a company's financial statements. For Hospital Mater Dei (BSP:MATD3), the current Accounts Payable & Accrued Expense is R$261 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hospital Mater Dei (BSP:MATD3) Overvalued in 2026?

Based on GuruFocus' analysis, Hospital Mater Dei stock appears to be undervalued. The current stock price of R$4.94 is trading 12.9% below its estimated GF Value™ of R$5.67. GuruFocus considers Hospital Mater Dei to be Modestly Undervalued.

Key valuation signals for BSP:MATD3:

  • Accounts Payable & Accrued Expense: R$261 Mil
  • GF Value™: R$5.67 vs. price of R$4.94 (12.9% below fair value)
  • GF Score™: 83/100 with 3 warning signs

No single metric tells the full story. See the BSP:MATD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hospital Mater Dei Business Description

Address Rua Mato Grosso, No. 1, 100, Bairro Santo Agostinho, Belo Horizonte, MG, BRA, 30.190-081
Hospital Mater Dei SA is an integrated healthcare ecosystem that provides hospital and oncological services. The company provides a wide range of healthcare services, including hospitalizations, surgeries, oncology treatments, medical appointments, and diagnostic exams.
83GF Score

Get the complete analysis for BSP:MATD3

Accounts Payable & Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$4.94
Price
R$5.67
GF Value